2024-12-26 13:45:46
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS
Health/ 2023-07-22
DEBIOPHARM APPLIES EXTENDED-RELEASE FORM...

- Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly...

iNtRON is finalizing the SAL200 Tech Transfer
Corporate/ 2023-07-24
iNtRON is finalizing the SAL200 Tech Tra...

Including the contract transfers of the external studies planned for the successful out-licensing and commercialization of SAL200

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release